Pseudohyperparathyreoidism is characterized by hypercalcemia and hypophosphatemia with hypercalciuria and hyperphosphaturia in the presence of suppressed PTH and PTH-related Protein.
1. |
Gordon SL et al. (1976) Jansen's metaphyseal dysostosis. |
2. |
Chen L et al. (2001) A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. |
4. |
Mahon MJ et al. (2002) Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. |
6. |
Rozeman LB et al. (2004) Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. |
7. |
Scillitani A et al. (2006) A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women. |
8. |
Wang B et al. (2008) Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. |
9. |
Karaplis AC et al. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. |
10. |
Hopyan S et al. (2002) A mutant PTH/PTHrP type I receptor in enchondromatosis. |
11. |
Holthusen W et al. (1975) The skull in metaphyseal chondrodysplasia type Jansen. |
12. |
None (1969) Metaphyseal dysostosis of Jansen. |
13. |
de Haas WH et al. (1969) Metaphysial dysostosis. A late follow-up of the first reported case. |
14. |
Charrow J et al. (1984) The Jansen type of metaphyseal chondrodysplasia: confirmation of dominant inheritance and review of radiographic manifestations in the newborn and adult. |
15. |
Kruse K et al. (1993) Calcium metabolism in the Jansen type of metaphyseal dysplasia. |
17. |
None (2002) Some chondrodysplasias with short limbs: molecular perspectives. |
18. |
Fukumoto S et al. (1996) Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib. |
19. |
Loshkajian A et al. (1997) Familial Blomstrand chondrodysplasia with advanced skeletal maturation: further delineation. |
20. |
Jobert AS et al. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. |
21. |
Zhang P et al. (1998) A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. |
22. |
Hoogendam J et al. (2007) Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II. |
23. |
Duchatelet S et al. (2005) Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes. |
24. |
Decker E et al. (2008) PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption. |
25. |
Lanske B et al. (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. |
26. |
Schipani E et al. (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. |
27. |
Minagawa M et al. (2001) Analysis of the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene in pseudohypoparathyroidism type 1b. |
28. |
Schipani E et al. (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. |
29. |
Parfitt AM et al. (1996) Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism. |
31. |
Schipani E et al. (1999) A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia. |
32. |
Karperien M et al. (1999) A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. |
33. |
Manen D et al. (2000) Positive and negative control of the expression of parathyroid hormone (PTH)/PTH-related protein receptor via proximal promoter P3 in human osteoblast-like cells. |
34. |
OMIM.ORG article Omim 168468 |